A Future
circleWithoutMalaria

Innovative, bloodless, automated, and rapid diagnosis and prescription for a healthier tomorrow

bricks
OUR RATIONALE

Why We Do What We Do

Malaria remains a leading cause of illness and death in many countries. Over 200 million cases are reported annually, with the majority (94%) being in sub-Saharan Africa. As a result, 95% of Malaria deaths occur in the region.

Children under five are particularly vulnerable, with one child dying every two minutes from malaria. These are not just statistics – they are real lives, real families, and real futures at stake.

Source: World Malaria Report 2023 by WHO
boys

249M

Malaria cases in 2022

608K

Malaria deaths in 2022

cool

The Urgency of Early Malaria Diagnosis

Current diagnostic methods are often invasive, time-consuming, and inaccessible to those in remote areas.

According to the Malaria Journal, community-based early diagnosis and treatment are crucial in reducing malaria deaths. These methods prevent transmission, lower recurrence rates, and are cost-effective, especially in resource-limited settings. Furthermore, early diagnosis and treatment within 24-48 hours of fever onset significantly reduce parasite transmission, thereby preventing further infections.

This reality drives our unwavering commitment to developing a more effective, accessible, and non-invasive diagnostic tool. Our mission is to save lives and bring hope to communities burdened by malaria.

Source: Malaria Journal
leftleft

Our Journey

A timeline of MariTest’s development, highlighting the dedication and milestones reached.

group

Our Sponsors & Partners

logos
logos
logos
logos
logos

Support

Partner

Join

Contact Us